Sava Infond’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$711K Buy
2,180
+100
+5% +$32.6K 0.11% 110
2025
Q1
$562K Buy
2,080
+350
+20% +$94.5K 0.11% 117
2024
Q4
$407K Buy
+1,730
New +$407K 0.07% 126